Ultragenyx Provides Financial and Business Updates at J.P. Morgan Annual Healthcare Conference
Ultragenyx Pharmaceutical Inc. Preliminary 2025 total revenue of $672 million to $674 million, exceeding top end of guidance Preliminary cash and...
Morgan
Celltrion presents innovative drug pipeline and U.S. manufacturing and R&D expansion strategy at the 44th Annual J.P. Morgan Healthcare Conference
Celltrion outlines a blueprint for innovative drug development built on its antibody expertise The company highlights its business strategy to...
How Is Morgan Stanley’s Stock Performance Compared to Other Capital Market Stocks
Morgan Stanley (MS) is a leading global financial services firm headquartered in New York. Its market cap is around $268.1...
Hotel MOHI names new sales, marketing director | Morgan Hill Times
Hotel MOHI by Appellation, expected to open in downtown Morgan Hill in early 2026, recently appointed Jennifer Van Every as...
30 Years of Foresight: The 2026 J.P. Morgan Long-Term Capital Market Assumptions in Focus
DISCLOSURES The information presented is not intended to be making value judgments on the preferred outcome of any government...
J.P. Morgan Releases 2026 LTCMAs: Sixty-Forty Return 6.4%
This year marks the flagship report's 30th anniversary, showcasing J.P. Morgan's long-standing market expertise and leading research capabilities NEW YORK,...
J.P. Morgan Releases 2026 Long-Term Capital Market Assumptions, Highlighting Resilient 60/40 Portfolios and Opportunities to Enhance Diversification in a New Era of Economic Nationalism and AI Advancement
This year marks the flagship report's 30th anniversary, showcasing J.P. Morgan's long-standing market expertise and leading research capabilities NEW YORK,...
ATB Capital and Morgan Stanley analysts reveal their top picks in the energy sector
Daily roundup of research and analysis from The Globe and Mail’s market strategist Scott BarlowATB Capital Markets analysts Patrick O’Rourke...
Introducing the 29th Edition of J.P. Morgan Asset Management’s Long-Term Capital Market Assumptions
DISCLOSURES The information presented is not intended to be making value judgments on the preferred outcome of any government...
